1. Home
  2. RGC vs NAN Comparison

RGC vs NAN Comparison

Compare RGC & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGC
  • NAN
  • Stock Information
  • Founded
  • RGC 2014
  • NAN 1999
  • Country
  • RGC Hong Kong
  • NAN United States
  • Employees
  • RGC N/A
  • NAN N/A
  • Industry
  • RGC Medicinal Chemicals and Botanical Products
  • NAN Investment Managers
  • Sector
  • RGC Health Care
  • NAN Finance
  • Exchange
  • RGC Nasdaq
  • NAN Nasdaq
  • Market Cap
  • RGC 377.5M
  • NAN 345.4M
  • IPO Year
  • RGC 2021
  • NAN N/A
  • Fundamental
  • Price
  • RGC $718.00
  • NAN $11.29
  • Analyst Decision
  • RGC
  • NAN
  • Analyst Count
  • RGC 0
  • NAN 0
  • Target Price
  • RGC N/A
  • NAN N/A
  • AVG Volume (30 Days)
  • RGC 91.2K
  • NAN 74.6K
  • Earning Date
  • RGC 06-20-2025
  • NAN 01-01-0001
  • Dividend Yield
  • RGC N/A
  • NAN 4.37%
  • EPS Growth
  • RGC N/A
  • NAN N/A
  • EPS
  • RGC N/A
  • NAN N/A
  • Revenue
  • RGC N/A
  • NAN N/A
  • Revenue This Year
  • RGC N/A
  • NAN N/A
  • Revenue Next Year
  • RGC N/A
  • NAN N/A
  • P/E Ratio
  • RGC N/A
  • NAN N/A
  • Revenue Growth
  • RGC N/A
  • NAN N/A
  • 52 Week Low
  • RGC $3.03
  • NAN $9.11
  • 52 Week High
  • RGC $950.00
  • NAN $11.34
  • Technical
  • Relative Strength Index (RSI)
  • RGC 67.80
  • NAN 52.54
  • Support Level
  • RGC $476.79
  • NAN $11.19
  • Resistance Level
  • RGC $560.00
  • NAN $11.38
  • Average True Range (ATR)
  • RGC 134.54
  • NAN 0.11
  • MACD
  • RGC 34.08
  • NAN 0.01
  • Stochastic Oscillator
  • RGC 67.60
  • NAN 66.67

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: